Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study to Assess Nirsevimab Immunization Rates in Eligible Infants During Their First RSV Season in the Czechia

NCT07634692 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT07634692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07634692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study to Assess Nirsevimab Immunization Rates in Eligible Infants During Their First RSV Season in the Czechia
Lead sponsor
Sanofi
Phase
Observational
Overall status
Completed
Start date
June 15, 2026
Completion date
June 26, 2026
Enrollment
257 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rsv immunization